Intuitive Surgical, Inc. (ISRG) Shares Bought by Bank of New York Mellon Corp

Bank of New York Mellon Corp boosted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.1% in the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 3,040,641 shares of the medical equipment provider’s stock after acquiring an additional 1,672 shares during the period. Bank of New York Mellon Corp owned 2.67% of Intuitive Surgical worth $1,454,886,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently bought and sold shares of the stock. Wedbush Securities Inc. grew its stake in Intuitive Surgical by 1.4% during the second quarter. Wedbush Securities Inc. now owns 7,086 shares of the medical equipment provider’s stock valued at $3,391,000 after acquiring an additional 98 shares in the last quarter. Securian Asset Management Inc grew its stake in Intuitive Surgical by 0.9% during the second quarter. Securian Asset Management Inc now owns 11,795 shares of the medical equipment provider’s stock valued at $5,644,000 after acquiring an additional 100 shares in the last quarter. Sun Life Financial INC grew its stake in Intuitive Surgical by 59.9% during the second quarter. Sun Life Financial INC now owns 307 shares of the medical equipment provider’s stock valued at $147,000 after acquiring an additional 115 shares in the last quarter. Envestnet Asset Management Inc. grew its stake in Intuitive Surgical by 2.8% during the second quarter. Envestnet Asset Management Inc. now owns 4,229 shares of the medical equipment provider’s stock valued at $2,022,000 after acquiring an additional 117 shares in the last quarter. Finally, Financial Counselors Inc. grew its stake in Intuitive Surgical by 3.2% during the second quarter. Financial Counselors Inc. now owns 3,833 shares of the medical equipment provider’s stock valued at $1,834,000 after acquiring an additional 118 shares in the last quarter. 84.83% of the stock is owned by institutional investors.

ISRG has been the subject of several research analyst reports. Piper Jaffray Companies raised shares of Intuitive Surgical from a “neutral” rating to an “overweight” rating and set a $600.00 target price for the company in a research note on Tuesday, October 9th. Wells Fargo & Co raised their target price on shares of Intuitive Surgical from $575.00 to $635.00 and gave the company an “outperform” rating in a research note on Wednesday, September 12th. Zacks Investment Research raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating and set a $582.00 target price for the company in a research note on Tuesday, July 24th. BidaskClub cut shares of Intuitive Surgical from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, July 31st. Finally, Cantor Fitzgerald reaffirmed a “buy” rating and set a $620.00 target price (up from $510.00) on shares of Intuitive Surgical in a research note on Friday, July 20th. One research analyst has rated the stock with a sell rating, four have given a hold rating and seventeen have issued a buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus target price of $554.01.



Shares of NASDAQ:ISRG opened at $486.89 on Friday. Intuitive Surgical, Inc. has a 52 week low of $359.75 and a 52 week high of $581.12. The firm has a market capitalization of $56.29 billion, a price-to-earnings ratio of 67.72, a price-to-earnings-growth ratio of 3.31 and a beta of 0.89.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, October 18th. The medical equipment provider reported $2.83 EPS for the quarter, topping analysts’ consensus estimates of $2.66 by $0.17. Intuitive Surgical had a net margin of 22.31% and a return on equity of 18.79%. The business had revenue of $920.90 million during the quarter, compared to analysts’ expectations of $916.22 million. During the same period last year, the company posted $2.77 EPS. The business’s revenue was up 14.0% on a year-over-year basis. As a group, sell-side analysts anticipate that Intuitive Surgical, Inc. will post 9.52 earnings per share for the current fiscal year.

In other news, CEO Gary S. Guthart sold 35,672 shares of the firm’s stock in a transaction dated Monday, August 6th. The shares were sold at an average price of $520.24, for a total value of $18,558,001.28. Following the completion of the sale, the chief executive officer now owns 363,542 shares in the company, valued at approximately $189,129,090.08. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, VP Jamie Samath sold 864 shares of the firm’s stock in a transaction dated Tuesday, October 23rd. The stock was sold at an average price of $499.21, for a total transaction of $431,317.44. Following the completion of the sale, the vice president now owns 257 shares of the company’s stock, valued at approximately $128,296.97. The disclosure for this sale can be found here. Insiders sold a total of 83,753 shares of company stock valued at $42,966,655 over the last three months. Corporate insiders own 2.20% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. The company's da Vinci surgical System translates a surgeon's natural hand movements, which are performed on instrument controls at a console into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.

Further Reading: Do stock splits help investors?

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply